tm
Seeing Is Believing
tm
Seeing Is Believing
BTX is currently covered by 1 analysts with an average price target of $9.21. This is a potential upside of $4.24 (85.31%) from yesterday's end of day stock price of $4.97.
Brooklyn Immunotherapeutics's activity chart (see below) currently has 2 price targets and 5 ratings on display. The stock rating distribution of BTX is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 136 days.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 12-Oct-2022. First documented stock forecast 24-Jan-2019.
Currently out of the existing stock ratings of BTX, 1 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
5
1 years 10 months 25 days ago
1/2 (50%)
$3.65 (270.37%)
272
Buy
9
$8.79 (4185.71%)
2 years 8 months 7 days ago
0/1 (0%)
$4.83 (115.83%)
What is BTX (Brooklyn Immunotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BTX (Brooklyn Immunotherapeutics) with a proven track record?
Which analyst has the current lower performing score on BTX (Brooklyn Immunotherapeutics) with a proven track record?
Which analyst has the most public recommendations on BTX (Brooklyn Immunotherapeutics)?
Which analyst is the currently most bullish on BTX (Brooklyn Immunotherapeutics)?
Which analyst is the currently most reserved on BTX (Brooklyn Immunotherapeutics)?
